Yazar "Terzi Y." için listeleme
-
18F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer
Kurtipek E.; Çayci M.; Düzgün N.; Esme Hi.; Terzi Y.; Bakdik S.; Bekci T.T. (Lippincott Williams and Wilkins, 2015)Objective: The study was designed to determine the relationship between survival time of standardized uptake value (SUVmax and SUVmean) and metabolic tumor volume (MTV) in patients with non-small cell lung cancer (NSCLC), ... -
Analysis of proportional hazards assumption in Cox regression model using residuals and an application on lung cancer patients
Terzi Y.; Cengiz M.A.; Bek Y. (Turkiye Klinikleri, 2005)Objective: To aim of this study was to investigate proportional hazards assumption in Cox regression model with application to patients with lung cancer. Material and Methods: Two-hundred twenty-seven patients with lung ... -
Assessment of soluble urokinase-type plasminogen activator receptor (suPAR) in chronic obstructive pulmonary disease
Kurtipek E.; Kesli R.; Bekçi T.T.; Eroğlu F.; Akin B.; Kurku H.; Terzi Y. (BioMed Central Ltd., 2015)Background: Chronic obstructive pulmonary disease (COPD) is a disease characterized by a progressive airflow limitation. Soluble urokinase-type plasminogen activator receptor (suPAR) is released from the membrane-bound ... -
Investigation of the relation between anaerobic bacteria genus clostridium and late-onset autism etiology in children
The aim of this study was to investigate the relation between the etiology of late-onset childhood autism and anaerobic bacteria. Thirty children diagnosed with autistic disorder and control group have been included in the ... -
Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in behçet’s disease and correlation with disease activity
Saylam Kurtipek G.; Kesli R.; Tuncez Akyurek F.; Akyurek F.; Ataseven A.; Terzi Y. (Blackwell Publishing, 2018)Background: Soluble urokinase plasminogen activator receptor (suPAR), a new biomarker, is a soluble form of membrane-bound receptors secreted from different immune cells. The aim of the present study is to determine plasma ... -
Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in psoriasis patients and correlation with disease severity
Kurtipek G.S.; Kesli R.; Akyürek F.T.; Akyüret F.; Terzi Y. (Slovenian Medical Society, 2015)Objective: Psoriasis is a chronic, relapsing, inflammatory, hyper-proliferative skin disease. Plasma-soluble urokinase plasminogen activator receptor (suPAR) is released from the cell membrane-bound plasminogen activator ... -
Reliability of stool antigen tests: Investigation of the diagnostic value of a new immunochromatographic Helicobacter pylori approach in dyspeptic patients
Korkmaz H.; Findik D.; Ugurluoglu C.; Terzi Y. (Asian Pacific Organization for Cancer Prevention, 2015)Background: A diagnosis of H. pylori infection can be made by invasive or non-invasive methods. Several noninvasive diagnostic tests based on the detection of H. pylori stool antigen (HpSA) have been developed. The Genx ...
